In this study, we investigated if non-traditional measures of inflammation such as IFNg, IL8, Flt3-ligand, insulin, and survivin combined with the RA classification criteria are useful for estimation of MTX response in patients with early treatment-naïve inflammatory arthritis. This evidence concerns the gene FLT3LG and rheumatoid arthritis.